Prevalence and correlates of previous hepatitis B vaccination and infection among young drug-users in New York City

Journal of Community Health

Volumn 33, Issue 3, 2008, Pages 139-148

  Amesty, S ^a   Ompad, D C ^b   Galea, S ^b,c   Fuller, C M ^b,d   Wu, Y ^e   Koblin, B ^d,f   Vlahov, D ^b,d  

^a Columbia University ^*  (United States)

^b NEW YORK ACADEMY OF MEDICINE   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

^d Department of Medicine   (United States)

^e WEILL CORNELL MEDICAL COLLEGE   (United States)

^f NEW YORK BLOOD CENTER   (United States)

Author keywords

Hepatitis B; Substance use; Vaccination

Indexed keywords

ADULT; ARTICLE; BIVARIATE ANALYSIS; COMMUNITY CARE; CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE PREDISPOSITION; DRUG USE; FEMALE; HEALTH PROGRAM; HEPATITIS B; HISPANIC; HOMELESSNESS; HUMAN; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MALE; PREVALENCE; SEROLOGY; SOCIAL CLASS; TEACHER; VACCINATION;

ADOLESCENT; ADULT; AGE FACTORS; FEMALE; HEPATITIS B; HEPATITIS B VACCINES; HIV INFECTIONS; HUMANS; MALE; NEW YORK CITY; PREVALENCE; QUESTIONNAIRES; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES; SEXUAL BEHAVIOR; SOCIAL CLASS; SUBSTANCE-RELATED DISORDERS; VACCINATION;

EID: 43349086736     PISSN: 00945145     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10900-007-9082-4     Document Type: Article

References (54)

1. Coleman, P. J., McQuillan, G. M., Moyer, L. A., Lambert, S. B., & Margolis, H. S. (1998). Incidence of hepatitis B virus infection in the United States, 1976-1994: Estimates from the national health and nutrition examination surveys. Journal of Infectious Diseases, 178(4), 954-959.
2. Centers for Disease Control and Prevention. Hepatitis Surveillance. Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention; 2005. Report No.: 60.
3. Margolis, H. S., Coleman, P. J., Brown, R. E., Mast, E. E., Sheingold, S. H., & Arevalo, J. A. (1995). Prevention of hepatitis B virus transmission by immunization. An economic analysis of current recommendations. JAMA, 274(15), 1201-1208.
4. Custer B., Sullivan S. D., Hazlet T. K., Iloeje U., Veenstra D. L., & Kowdley, K. V. (2004). Global epidemiology of hepatitis B virus. Journal of Clinical Gastroenterology, 38(10 Suppl), S158-S168.
5. Glynn, S. A., Kleinman, S. H., Schreiber, G. B., et al. (2000). Trends in incidence and prevalence of major transfusion-transmissible viral infections in US blood donors, 1991 to 1996. Retrovirus Epidemiology Donor Study (REDS). JAMA, 284(2), 229-235.
6. Alter, M. J., Hadler, S. C., Margolis, H. S., et al. (1990). The changing epidemiology of hepatitis B in the United States. Need for alternative vaccination strategies. JAMA, 263(9), 1218-1222.
7. Murrill, C. S., Weeks, H., Castrucci, B. C., et al. (2002). Age-specific seroprevalence of HIV, hepatitis B virus, and hepatitis C virus infection among injection drug users admitted to drug treatment in 6 US cities. American Journal of Public Health, 92(3), 385-387.
8. Hepatitis B vaccination for injection drug users-Pierce County, Washington, 2000. (2001). MMWR Morbidity and Mortality Weekly Report, 50(19), 388-390, 399.
9. Advisory Committee on Immunization Practices. (1991). Hepatitis B virus: A comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination: Recommendations of the Immunization Practices Advisory Committee. MMWR Morbidity and Mortality Weekly Report 40(RR13), 1-25.
10. American Academy of Pediatrics CoID (1992). Universal hepatitis B vaccination. Pediatrics, 89, 795-800.
11. Hepatitis B vaccination coverage among adults-United States, 2004. (2006). MMWR Morbidity and Mortality Weekly Report, 55(18), 509-511.
12. Mast, E. E., Margolis, H. S., Fiore, A. E., et al. (2005). A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: Recommendations of the advisory committee on immunization practices (ACIP) part 1: Immunization of infants, children, and adolescents. MMWR Morbidity and Mortality Weekly Report, 54(RR-16), 1-31.
13. MacKellar, D. A., Valleroy, L. A., Secura, G. M., et al. (2001). Two decades after vaccine license: Hepatitis B immunization and infection among young men who have sex with men. American Journal of Public Health, 91(6), 965-971.
14. Diaz, T., Des, J., Vlahov, D., et al. (2001). Factors associated with prevalent hepatitis C: Differences among young adult injection drug users in lower and upper Manhattan, New York City. American Journal of Public Health, 91(1), 23-30.
15. Diaz, T., Vlahov, D., Greenberg, B., Cuevas, Y., & Garfein, R. (2001). Sexual orientation and HIV infection prevalence among young Latino injection drug users in Harlem. Journal of Womens Health Gender Based Medicine, 10(4), 371-380.
16. Ompad, D. C., Galea, S., Wu, Y., et al. (2004). Acceptance and completion of hepatitis B vaccination among drug users in New York City. Communicable Disease and Public Health, 7(4), 294-300.
17. Heimer, R., Clair, S., Grau, L. E., Bluthenthal, R. N., Marshall, P. A., & Singer, M. (2002). Hepatitis-associated knowledge is low and risks are high among HIV-aware injection drug users in three US cities. Addiction, 97(10), 1277-1287.
18. Hagan, H., Thiede, H., McGough, J. P., & Alexander, E. R. (2002). Hepatitis B vaccination among research participants, Seattle, Washington. American Journal of Public Health, 92(11), 1756.
19. Kottiri, B. J., Friedman, S. R., Euler, G. L., et al. (2005). A community-based study of hepatitis B infection and immunization among young adults in a high-drug-use neighborhood in New York City. Journal of Urban Health, 82(3), 479-487.
20. Levine, O. S., Vlahov, D., Koehler, J., Cohn, S., Spronk, A. M., & Nelson, K. E. (1995). Seroepidemiology of hepatitis B virus in a population of injecting drug users. Association with drug injection patterns. American Journal of Epidemiology, 142(3), 331-341.
21. Immunization Action Coalition. Hepatitis B Prevention Mandates. 1-31-2006. Ref Type: Internet Communication.
22. Garfein, R. S., Vlahov, D., Galai, N., Doherty, M. C., & Nelson, K. E. (1996). Viral infections in short-term injection drug users: The prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses. American Journal of Public Health, 86(5), 655-661.
23. Gershon, R. R., Mitchell, C., Sherman, M. F., et al. (2005). Hepatitis B vaccination in correctional health care workers. American Journal of Infection Control, 33(9), 510-518.
24. Mahoney, F. J., Stewart, K., Hu, H., Coleman, P., & Alter, M. J. (1997). Progress toward the elimination of hepatitis B virus transmission among health care workers in the United States. Archives of Internal Medicine, 157(22), 2601-2605.
25. Rhodes, S. D., & Hergenrather, K. C. (2002). Exploring hepatitis B vaccination acceptance among young men who have sex with men: facilitators and barriers. Preventive Medicine, 35(2), 128-134.
26. Rhodes, S. D., DiClemente, R. J., Yee, L. J., & Hergenrather, K. C. (2001). Correlates of hepatitis B vaccination in a high-risk population: an Internet sample. American Journal of Medicine, 110(8), 628-632.
27. Hepatitis B vaccination among high-risk adolescents and adults-San Diego, California, 1998-2001. (2002). MMWR Morbidity and Mortality Weekly Report, 51(28), 618-621.
28. Remis, R. S., Dufour, A., Alary, M., et al. (2000). Association of hepatitis B virus infection with other sexually transmitted infections in homosexual men. Omega Study Group. American Journal of Public Health, 90(10), 1570-1574.
29. Zimet, G. D., Kee, R., Winston, Y., Perkins, S. M., & Maharry, K. (2001). Acceptance of hepatitis B vaccination among adult patients with sexually transmitted diseases. Sexually Transmitted Diseases, 28(11), 678-680.
30. Sellors, J., Zimic-Vincetic, M., Howard, M., Mahony, J. B., & Chernesky, M. A. (1998). Predictors of positivity for hepatitis B and the derivation of a selective screening rule in a Canadian sexually transmitted disease clinic. Journal of Clinical Virology, 11(1), 85-91.
31. Folstein, M. F., Bassett, S. S., Anthony, J. C., Romanoski, A. J., & Nestadt, G. R. (1991). Dementia: Case ascertainment in a community survey. Journal of Gerontology, 46(4), M132-M138.
32. Thiede, H., Romero, M., Bordelon, K., Hagan, H., & Murrill, C. S. (2001). Using a jail-based survey to monitor HIV and risk behaviors among Seattle area injection drug users. Journal of Urban Health, 78(2), 264-278.
33. Carey, J., Perlman, D. C., Friedmann, P., et al. (2005). Knowledge of hepatitis among active drug injectors at a syringe exchange program. Journal of Substance Abuse Treatment, 29(1), 47-53.
34. Samoff, E., Dunn, A., VanDevanter, N., Blank, S., & Weisfuse, I. B. (2004). Predictors of acceptance of hepatitis B vaccination in an urban sexually transmitted diseases clinic. Sexually Transmitted Diseases, 31(7), 415-420.
35. Seal, K. H., Ochoa, K. C., Hahn, J. A., Tulsky, J. P., Edlin, B. R., & Moss, A. R. (2000). Risk of hepatitis B infection among young injection drug users in San Francisco: Opportunities for intervention. Western Journal of Medicine, 172(1), 16-20.
36. Des Jarlais, D. C., Fisher, D. G., Newman, J. C., et al. (2001). Providing hepatitis B vaccination to injection drug users: Referral to health clinics vs on-site vaccination at a syringe exchange program. American Journal of Public Health, 91(11), 1791-1792.
37. Kuo, I., Sherman, S. G., Thomas, D. L., & Strathdee, S. A. (2004). Hepatitis B virus infection and vaccination among young injection and non-injection drug users: Missed opportunities to prevent infection. Drug and Alcohol Dependence, 73(1), 69-78.
38. Lum, P. J., Ochoa, K. C., Hahn, J. A., Page, S. K., Evans, J. L., & Moss, A. R. (2003). Hepatitis B virus immunization among young injection drug users in San Francisco, Calif: The UFO Study. American Journal of Public Health, 93(6), 919-923.
39. Mezzelani, P., Venturini, L., Turrina, G., Lugoboni, F., & Des, J. (1991). High compliance with a hepatitis B virus vaccination program among intravenous drug users. Journal of Infectious Diseases, 163(4), 923.
40. Quaglio, G., Talamini, G., Lugoboni, F., et al. (2002). Compliance with hepatitis B vaccination in 1175 heroin users and risk factors associated with lack of vaccine response. Addiction, 97(8), 985-992.
41. Borg, L., Khuri, E., Wells, A., et al. (1999). Methadone-maintained former heroin addicts, including those who are anti-HIV-1 seropositive, comply with and respond to hepatitis B vaccination. Addiction, 94(4), 489-493.
42. Rodrigo, J. M., Serra, M. A., Aparisi, L., et al. (1992). Immune response to hepatitis B vaccine in parenteral drug abusers. Vaccine, 10(11), 798-801.
43. Rumi, M., Colombo, M., Romeo, R., et al. (1991). Suboptimal response to hepatitis B vaccine in drug users. Archives of Internal Medicine, 151(3), 574-578.
44. Gyarmathy, V. A., Neaigus, A., Miller, M., Friedman, S. R., & Des, J. (2002). Risk correlates of prevalent HIV, hepatitis B virus, and hepatitis C virus infections among noninjecting heroin users. Journal of Acquired Immune Deficiency Syndromes, 30(4), 448-456.
45. Hwang, L. Y., Ross, M. W., Zack, C., Bull, L., Rickman, K., & Holleman, M. (2000). Prevalence of sexually transmitted infections and associated risk factors among populations of drug abusers. Clinical of Infectious Diseases, 31(4), 920-926.
46. Thomas, D. L., Cannon, R. O., Shapiro, C. N., Hook, E. W. III, Alter, M. J., & Quinn, T. C. (1994). Hepatitis C, hepatitis B, and human immunodeficiency virus infections among non-intravenous drug-using patients attending clinics for sexually transmitted diseases. Journal of Infectious Diseases, 169(5), 990-995.
47. Friedland, G. H., Saltzman, B. R., Rogers, M. F., et al. (1986). Lack of transmission of HTLV-III/LAV infection to household contacts of patients with AIDS or AIDS-related complex with oral candidiasis. New England Journal of Medicine, 314(6), 344-349.
48. Nordenfelt, E., & Dahlquist, E. (1978). HBsAg positive adopted children as a cause of intrafamilial spread of hepatitis B. Scandinavian Journal of Infectious Diseases, 10(3), 161-163.
49. Carneiro, M., Fuller, C., Doherty, M. C., & Vlahov, D. (1999). HIV prevalence and risk behaviors among new initiates into injection drug use over the age of 40 years old. Drug and Alcohol Dependence, 54(1), 83-86.
50. van Ameijden, E. J., van den Hoek, J. A., Hartgers, C., & Coutinho, R. A. (1994). Risk factors for the transition from noninjection to injection drug use and accompanying AIDS risk behavior in a cohort of drug users. American Journal of Epidemiology, 139, 1153-1163.
51. Fuller, C. M., Vlahov, D., Latkin, C. A., Ompad, D. C., Celentano, D. D., & Strathdee, S. A. (2003). Social circumstances of initiation of injection drug use and early shooting gallery attendance: Implications for HIV intervention among adolescent and young adult injection drug users. Journal of Acquired Immune Deficiency Syndrome, 32(1), 86-93.
52. Francis, D. P., Hadler, S. C., Prendergast, T. J., et al. (1984). Occurrence of hepatitis A, B, and non-A/non-B in the United States. CDC sentinel county hepatitis study I. American Journal of Medicine, 76(1), 69-74.
53. Butterfield, M. I., Bosworth, H. B., Stechuchak, K. M., et al. (2004). Racial differences in hepatitis B and hepatitis C and associated risk behaviors in veterans with severe mental illness. Journal of Natural Medicine Association, 96(1), 43-52.
54. Landis, J. R., & Koch, G. G. (1977). The measurement of observer agreement for categorical data. Biometrics, 33(1), 159-174.